Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Kentucky
Merck Sharp & Dohme LLC
University of California, Davis
University of Michigan Rogel Cancer Center
Royal Marsden NHS Foundation Trust
City of Hope Medical Center
University of Pittsburgh
University of Chicago
Case Comprehensive Cancer Center
Icahn School of Medicine at Mount Sinai
Eastern Cooperative Oncology Group
CEL-SCI Corporation
Ohio State University Comprehensive Cancer Center
Bristol-Myers Squibb
University of Michigan Rogel Cancer Center
University of Colorado, Denver
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiation Therapy Oncology Group
Masonic Cancer Center, University of Minnesota
University of Washington
Radiation Therapy Oncology Group
Case Comprehensive Cancer Center
Duke University
Roswell Park Cancer Institute
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
GlaxoSmithKline
AstraZeneca